Medical Devices Needed to Boost Access, Home CareTue, 04/30/2019 - 11:41
Q: How has Johnson & Johnson evolved to make its offering stand out in the market?
A: Around 10 years ago, our medical devices division focused on the product itself. The premise was to differentiate ourselves by developing products that were faster, reduced bleeding or helped the patient recover faster. Today, our focus has evolved from products and services to solutions. Instead of just focusing on technology, this new approach has broadened our vision by putting patients front and center and integrating our products and services to offer a holistic solution.
Talking about solutions also forces us to consider all players and elements that impact the health ecosystem and how different actors can share risks and benefits. The idea is to create a more integral environment that considers prevention, diagnosis, treatment, rehabilitation and reincorporation to normal life. We do not only focus on the operational part of the business; we have a responsibility to listen and generate solutions for the future.
Q: What elements should be taken into consideration to ensure universal health access in the country?
A: The definition of access changes depending on how you ask. According to some, access entails free medicine for everyone, which generates the dilemma of how to ensure free and universal availability. However, when talking about access, we also need to consider quality, the patient’s clinical outcome and patient satisfaction. Quality always needs to be part of the overall health ecosystem; it cannot be negotiated neither for medicines nor medical devices. A patient’s clinical result must always be analyzed according to that patient’s lifestyle, considering economic costs and the responsible use of technology.
Q: How can the private and public sectors work together to increase healthcare access in remote and hard-to-access areas?
A: We cannot build a hospital in every town in the country. There is not enough money to build so many projects or to properly equip them. Similarly, there are not enough doctors and nurses to work in every municipality. This means we need to start using different technologies and work on a collaboration strategy.
An example is using the existing private sector infrastructure to provide better public health services. We are working on a project with the Ministry of Health of Coahuila to address cases of morbid obesity in the state. By drawing from our experience working with other local ministries of health and specialized centers, we helped the Ministry of Health of Coahuila generate an integral plan for treating these patients.
Q: What opportunities has Johnson & Johnson identified in medical devices for homecare and how can they contribute to boost prevention?
A: Hospitals should be for people with critical conditions. We are making a lot of changes in our portfolio and even though we have not necessarily made efforts to venture in this type of care, we have tried to reduce surgeries in hospitals. There are many surgeries that could be ambulatory, but that requires quality devices and proper protocols. Recently, we have also started selling our line of glucose monitors, which is No. 1 in the Mexican market.
Q: What are Johnson & Johnson’s main goals for 2019?
A: There is a great deal of uncertainty in the sector due to the changes the government wants to make. Although many of them are good, the administration should not move forward without knowing how the changes will be implemented. We do not know how the year will end, but we have a responsibility to participate in the debate regarding what is the best health system for the country to provide access to quality and affordable care. Our commitment to Mexico is to reach more patients and restore more lives.